EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Insufficient Plasma Melatonin and Its Association With Neuropsychiatric Impairments in Patients With T2DM

Shuai He, Yue Yu, Peng-Quan Chen, Hui-Min Sun, Xin-Ran Gao, Huai-Zhi Sun, Jin-Fang Ge iD

Journal of Diabetes Research · 2024

DOI: 10.1155/2024/5661751 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Diabetes Research, 2024. Verfasst von Shuai He und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Pharmacy Anhui Medical University, 81 Mei-Shan Road, Hefei 230032, China. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Melatonin, Glycated Hemoglobin, Cognitive Dysfunction. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 49 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Anhui Medical University, Anhui University, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Type 2 diabetes mellitus (T2DM) is associated with multiple neuropsychiatric impairments, including cognitive dysfunction, and melatonin (MLT) plays a crucial role in maintaining normal neuropsychiatric functions. This study is aimed at investigating the change in plasma MLT levels and its association with neuropsychiatric impairments in T2DM patients.

Methods

One hundred twenty‐six T2DM patients were recruited, and their demographics and clinical data were collected. Apart from the plasma glycated hemoglobin (HbA1c) levels and other routine metabolic indicators, the plasma concentrations of MLT, C‐reactive protein (CRP), Interleukin 6 (IL‐6), soluble myeloid triggered receptor 1 (sTREM 1), and receptor 2 (sTREM 2) were measured. Moreover, the executive function and depressive tendency were evaluated via the Behavior Rating Inventory of Executive Function‐Adult Version (BRIEF‐A) and the Epidemiological Research Center Depression Scale (CES‐D), respectively.

Result

Compared with the low HbA1c group, the T2DM patients in the high HbA1c group presented lower plasma MLT levels but higher plasma concentrations of inflammatory biomarker levels, together with higher scores in the BRIEF‐A and CES‐D scales. Moreover, results of the Pearson correlation test showed that the plasma MLT levels were negatively correlated with the BRIEF‐A and CES‐D scores, as well as plasma concentrations of HbA1c and inflammatory indications, indicating that MLT may mediate their neuroinflammation and neuropsychiatric impairments. Furthermore, the ROC curve results indicated that plasma MLT levels have a predictive effect on executive impairment and depressive status in T2DM patients.

Conclusion

MLT levels decreased in patients with T2DM and were associated with neuropsychiatric impairments and inflammatory status, and MLT might be developed as a therapeutic agent and predictive indicator for T2DM‐associated executive impairment and depression status.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2MelatoninGlycated HemoglobinCognitive DysfunctionDepressionBiomarkersHumansMaleFemaleMiddle AgedAgedAdultExecutive FunctionC-Reactive Protein

Stichwörter der Autor:innen

MLTT2DMmetabolic syndromeneuroinflammationneuropsychiatric impairments

Substanzen

MelatoninGlycated HemoglobinBiomarkershemoglobin A1c protein, humanC-Reactive Protein

Autor:innen und Institutionen

  • School of Pharmacy Anhui Medical University, 81 Mei-Shan Road, Hefei 230032, China.
  • The Key Laboratory of Anti-Inflammatory and Immune Medicine Ministry of Education Anhui Medical University, Hefei, China.
  • Anhui Provincial Laboratory of Inflammatory and Immunity Disease Anhui Institute of Innovative Drugs, Hefei, China.
  • Department of Pharmacy North District of The First Affiliated Hospital of Anhui Medical University, Hefei, China.

ORCID-Profile: Jin-Fang Ge

Förderung

  • Anhui Medical University
  • Anhui University
  • National Natural Science Foundation of China

Zitieren

APA

He, S., Yu, Y., Chen, P. Q., Sun, H. M., Gao, X. R., Sun, H. Z., & Ge, J. F. (2024). Insufficient Plasma Melatonin and Its Association With Neuropsychiatric Impairments in Patients With T2DM. Journal of Diabetes Research. https://doi.org/10.1155/2024/5661751

Vancouver

He S, Yu Y, Chen PQ, Sun HM, Gao XR, Sun HZ, et al. Insufficient Plasma Melatonin and Its Association With Neuropsychiatric Impairments in Patients With T2DM. Journal of Diabetes Research. 2024. doi:10.1155/2024/5661751

BibTeX
@article{He2024,
  author = {He, Shuai and Yu, Yue and Chen, Peng-Quan and Sun, Hui-Min and Gao, Xin-Ran and Sun, Huai-Zhi and Ge, Jin-Fang},
  title = {Insufficient Plasma Melatonin and Its Association With Neuropsychiatric Impairments in Patients With T2DM},
  journal = {Journal of Diabetes Research},
  year = {2024},
  doi = {10.1155/2024/5661751}
}
Kostenlos starten →